Unlike GHRP-2 or GHRP-6, research demonstrates that Ipamorelin does not stimulate the release of Adrenocorticotropic Hormone (ACTH), Cortisol, or Prolactin, even at high saturation levels
For more information c ontact us or click here to book a B12 injection with us
If, after consulting with a doctor, a young athlete is going to begin using a GLP-1 drug, its important to monitor the mental health and body image of your athlete, as well as their physical health
doi: 10.1371/journal.pone.0160221 Summary Keywords GLP-1 receptor agonists, gastrointestinal toxicities, adverse drug reactions, pharmacovigilance, data mining Citation Liu L, Chen J, Wang L, Chen C and Chen L (2022) Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database
Weight-related conditions (hypertension, dyslipidemia, OSA, pre-diabetes, PCOS) with medications and, if available, bloodwork
This designation allows use strictly for in vitro testing and laboratory experimentation